BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35917900)

  • 1. A case-control study of linear energy transfer and relative biological effectiveness related to symptomatic brainstem toxicity following pediatric proton therapy.
    Fjæra LF; Indelicato DJ; Handeland AH; Ytre-Hauge KS; Lassen-Ramshad Y; Muren LP; Stokkevåg CH
    Radiother Oncol; 2022 Oct; 175():47-55. PubMed ID: 35917900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
    Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
    Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
    Traneus E; Ödén J
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
    Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
    Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
    Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
    Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
    Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
    Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
    Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
    Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
    Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
    Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
    Henry T; Ödén J
    Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial Agreement of Brainstem Dose Distributions Depending on Biological Model in Proton Therapy for Pediatric Brain Tumors.
    Fjæra LF; Indelicato DJ; Ytre-Hauge KS; Muren LP; Lassen-Ramshad Y; Toussaint L; Dahl O; Stokkevåg CH
    Adv Radiat Oncol; 2021; 6(1):100551. PubMed ID: 33490724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear energy transfer-inclusive models of brainstem necrosis following proton therapy of paediatric ependymoma.
    Handeland AH; Indelicato DJ; Fredrik Fjæra L; Ytre-Hauge KS; Pettersen HES; Muren LP; Lassen-Ramshad Y; Stokkevåg CH
    Phys Imaging Radiat Oncol; 2023 Jul; 27():100466. PubMed ID: 37457667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of linear energy transfer computed in a Monte Carlo dose engine of a commercial treatment planning system.
    Wagenaar D; Tran LT; Meijers A; Marmitt GG; Souris K; Bolst D; James B; Biasi G; Povoli M; Kok A; Traneus E; van Goethem MJ; Langendijk JA; Rosenfeld AB; Both S
    Phys Med Biol; 2020 Jan; 65(2):025006. PubMed ID: 31801119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating variable RBE in IMPT optimization for ependymoma.
    Goudarzi HM; Lim G; Grosshans D; Mohan R; Cao W
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14207. PubMed ID: 37985962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
    Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
    Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposing a Clinical Model for RBE Based on Proton Track-End Counts.
    Henthorn NT; Gardner LL; Aitkenhead AH; Rowland BC; Shin J; Smith EAK; Merchant MJ; Mackay RI; Kirkby KJ; Chaudhary P; Prise KM; McMahon SJ; Underwood TSA
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):916-926. PubMed ID: 36642109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technical note: Investigation of dose and LET
    Yang Y; Rwigema JM; Vargas C; Yu NY; Keole SR; Wong WW; Schild SE; Bues M; Liu W; Shen J
    Med Phys; 2022 Dec; 49(12):7428-7437. PubMed ID: 36208196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.